GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » EV-to-EBITDA

Shenzhen Kangtai Biological Products Co (SZSE:300601) EV-to-EBITDA : 24.63 (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shenzhen Kangtai Biological Products Co's enterprise value is ¥21,740 Mil. Shenzhen Kangtai Biological Products Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥883 Mil. Therefore, Shenzhen Kangtai Biological Products Co's EV-to-EBITDA for today is 24.63.

The historical rank and industry rank for Shenzhen Kangtai Biological Products Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300601' s EV-to-EBITDA Range Over the Past 10 Years
Min: -189.13   Med: 80.88   Max: 235.87
Current: 24.63

During the past 12 years, the highest EV-to-EBITDA of Shenzhen Kangtai Biological Products Co was 235.87. The lowest was -189.13. And the median was 80.88.

SZSE:300601's EV-to-EBITDA is ranked worse than
75.91% of 714 companies
in the Drug Manufacturers industry
Industry Median: 14.065 vs SZSE:300601: 24.63

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Shenzhen Kangtai Biological Products Co's stock price is ¥17.45. Shenzhen Kangtai Biological Products Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.640. Therefore, Shenzhen Kangtai Biological Products Co's PE Ratio for today is 27.27.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shenzhen Kangtai Biological Products Co EV-to-EBITDA Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co EV-to-EBITDA Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.66 134.35 35.24 -1,276.56 25.09

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -119.13 119.02 86.14 25.09 29.55

Competitive Comparison of Shenzhen Kangtai Biological Products Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Kangtai Biological Products Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's EV-to-EBITDA falls into.



Shenzhen Kangtai Biological Products Co EV-to-EBITDA Calculation

Shenzhen Kangtai Biological Products Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=21740.018/882.669
=24.63

Shenzhen Kangtai Biological Products Co's current Enterprise Value is ¥21,740 Mil.
Shenzhen Kangtai Biological Products Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥883 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Kangtai Biological Products Co  (SZSE:300601) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shenzhen Kangtai Biological Products Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=17.45/0.640
=27.27

Shenzhen Kangtai Biological Products Co's share price for today is ¥17.45.
Shenzhen Kangtai Biological Products Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.640.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shenzhen Kangtai Biological Products Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines